years of
17 +
Years Peptide Expertise
Agile execution
7 kL
SPPS & LPPS Capacity
Proven regulatory track record
140,000 sq. f
Purpose-Built Peptide Facility
cGMP compliant
3 DAC
Columns Large-Scale Purification Infrastructure
Solving Complex Peptide Development Challenges

Peptide development is rarely straightforward. From insoluble sequences and impurity challenges to extended development timelines and regulatory hurdles, each step can introduce delays and risks that threaten your drug development program.

The Neuland Approach

Whether you’re working with small molecule peptides, SPPS, LPPS, or hybrid approaches, our integrated capabilities ensure: scalable and reproducible synthesis, rigorous impurity profiling and control, accelerated development timelines, and regulatory-ready documentation and compliance.

Custom Peptide Services

Neuland’s custom peptide synthesis services cover all the pharmaceutical and biotech industry’s peptide requirements. We specialize in the clinical development of simple to complex peptides synthesis and their commercial-scale manufacturing.

 

Process Optimization

Custom synthesis, route scouting, process development and validation, and impurity detection to ensure feasibility and optimization

Large-Scale Manufacturing

Comprehensive manufacturing solutions across scale - from clinical trial batches to full- scale commercial production of complex amino acids and FMOC-building blocks

Analytical R&D

Advanced R&D capabilities, including method validation, impurity profiling, and stability studies, supported by analytical reference standards

Drug Development Support

Raw material vendor evaluation and qualification, ensuring seamless scale-up across lab production, pilots, and commercial manufacturing

Regulatory Support

CMC preparation and review for peptide APIs, ensuring regulatory compliance with IMPD, IND, NDA, and ANDA registrations

Discuss Your Peptide Development or Manufacturing Requirements​

Discuss your peptide development, scale-up, or GMP manufacturing goals with our scientific experts. ​

From process optimization and technology transfer to commercial readiness, we help
advance your peptide program with confidence.​

CDMO_des1

Case Study

Innovative Synthesis of a 25AA Peptide: Resolving Peptide Synthesis challenges
Read more
Peptide Brochure

Peptide Brochure

Read more
Neuland’s State-of-the-Art Peptide Facility

Neuland’s State-of-the-Art Peptide Facility

Read more